Skip to main content

Table 1 Oncologic and renal function outcomes of patients

From: Percutaneous radiofrequency ablation with contrast-enhanced ultrasonography for solitary and sporadic renal cell carcinoma in patients with autosomal dominant polycystic kidney disease

Case

Age

Gender

Tumor size (cm)

Complication

Initial classification

Session

Pre-RFA GFR (mL/min/1.73 m2)

6 months post-RFAGFR (mL/min/1.73 m2)

Follow-up time (m)

Outcome

1

55

M

2.8

Limited perinephric hematoma

Papillary RCC

1

58.9

57.3

70

Free

2

57

F

5.2

None

Papillary RCC

2

53.4

52.2

7

Free

3

55

M

3.2

Small volume hematuria

Papillary RCC

1

61.2

62.3

33

Free

4

63

F

1.7

None

Clear cell

1

48.4

47.2

54

Free

5

73

F

3.1

None

Clear cell

1

50.7

50.1

21

Free